The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation - PubMed (original) (raw)
Review
The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation
Vito Ferro et al. Mini Rev Med Chem. 2004 Aug.
Abstract
Heparanase is an endo-beta-glucuronidase that degrades the glycosaminoglycan heparan sulfate, a major component of the extracellular matrix and basement membranes, and has been implicated in such processes as inflammation, angiogenesis and metastasis. The identification of inhibitors of heparanase is an attractive approach towards developing new therapeutics for metastatic tumours and chronic inflammatory diseases. This review focuses on heparanase inhibitors that have been isolated or synthesised to date. More recent developments in the understanding of heparanase structure and function that may ultimately aid in the future design of inhibitors with improved potency and specificity, are also discussed.
Similar articles
- Development of heparanase inhibitors for anti-cancer therapy.
Miao HQ, Liu H, Navarro E, Kussie P, Zhu Z. Miao HQ, et al. Curr Med Chem. 2006;13(18):2101-11. doi: 10.2174/092986706777935230. Curr Med Chem. 2006. PMID: 16918340 Review. - Heparanase Inhibitors in Cancer Progression: Recent Advances.
Kaur R, Deb PK, Diwan V, Saini B. Kaur R, et al. Curr Pharm Des. 2021;27(1):43-68. doi: 10.2174/1381612826666201113105250. Curr Pharm Des. 2021. PMID: 33185156 Review. - Oligosaccharides from fucosylated glycosaminoglycan prevent breast cancer metastasis in mice by inhibiting heparanase activity and angiogenesis.
Zhou L, Yin R, Gao N, Sun H, Chen D, Cai Y, Ren L, Yang L, Zuo Z, Zhang H, Zhao J. Zhou L, et al. Pharmacol Res. 2021 Apr;166:105527. doi: 10.1016/j.phrs.2021.105527. Epub 2021 Mar 2. Pharmacol Res. 2021. PMID: 33667689 - [Human heparanase: roles in invasion and metastasis of cancer].
Gohji K, Katsuoka Y, Okamoto M, Kamidono S, Kitazawa S, Toyoshima M, Dong J, Nakajima M. Gohji K, et al. Hinyokika Kiyo. 2000 Oct;46(10):757-62. Hinyokika Kiyo. 2000. PMID: 11215206 Review. Japanese. - Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H, Liu H, Chen Y, Xin X, Li J, Hou Y, Zhang Z, Zhang X, Xie C, Geng M, Ding J. Zhao H, et al. Cancer Res. 2006 Sep 1;66(17):8779-87. doi: 10.1158/0008-5472.CAN-06-1382. Cancer Res. 2006. PMID: 16951194
Cited by
- Heparanase induces Akt phosphorylation via a lipid raft receptor.
Ben-Zaken O, Gingis-Velitski S, Vlodavsky I, Ilan N. Ben-Zaken O, et al. Biochem Biophys Res Commun. 2007 Oct 5;361(4):829-34. doi: 10.1016/j.bbrc.2007.06.188. Epub 2007 Jul 24. Biochem Biophys Res Commun. 2007. PMID: 17689495 Free PMC article. - Versatile role of heparanase in inflammation.
Goldberg R, Meirovitz A, Hirshoren N, Bulvik R, Binder A, Rubinstein AM, Elkin M. Goldberg R, et al. Matrix Biol. 2013 Jun 24;32(5):234-240. doi: 10.1016/j.matbio.2013.02.008. Epub 2013 Mar 13. Matrix Biol. 2013. PMID: 23499528 Free PMC article. Review. - Heparanase: a target for drug discovery in cancer and inflammation.
McKenzie EA. McKenzie EA. Br J Pharmacol. 2007 May;151(1):1-14. doi: 10.1038/sj.bjp.0707182. Epub 2007 Mar 5. Br J Pharmacol. 2007. PMID: 17339837 Free PMC article. Review. - Salivary Heparanase Level Is a Potential Biomarker to Diagnose and Prognose the Malignant Salivary Gland Tumor.
Wu X, Yu J, Gao G, Wang X, Liu Y, Zhu S, Gong Z. Wu X, et al. PLoS One. 2015 Nov 16;10(11):e0143009. doi: 10.1371/journal.pone.0143009. eCollection 2015. PLoS One. 2015. PMID: 26569485 Free PMC article. - Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma.
Alshehri MA, Alshehri MM, Albalawi NN, Al-Ghamdi MA, Al-Gayyar MMH. Alshehri MA, et al. Oncol Lett. 2021 Feb;21(2):173. doi: 10.3892/ol.2021.12434. Epub 2021 Jan 4. Oncol Lett. 2021. PMID: 33552290 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources